BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Revolution Medicines, Inc.
Pfizer
Verastem, Inc.
Pfizer
Bristol-Myers Squibb
Trishula Therapeutics, Inc.
ImmunityBio, Inc.
Taiho Pharmaceutical Co., Ltd.
Cantargia AB
Eli Lilly and Company
Incyte Corporation
Gilead Sciences
M.D. Anderson Cancer Center
TG Therapeutics, Inc.